Sublingual Dexmedetomidine as a Potential New Treatment for Agitation

JAMA. 2022 Feb 22;327(8):723-725. doi: 10.1001/jama.2021.21313.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Dexmedetomidine*
  • Humans
  • Hypnotics and Sedatives
  • Psychomotor Agitation

Substances

  • Hypnotics and Sedatives
  • Dexmedetomidine